474 Results (Page 1 of 19)
US Markets Research Reports
US Oral Care Market Analysis
The US oral care market was valued at $14.8 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022 to 2030 and will reach $20.5 Bn in 2030. One of the main reasons propelling the growth of this market is increased awareness and an aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Koninklijke Philips N.V., Colgate-Palmolive Company, GlaxoSmithKline plc, Procter & Gamble, Johnson & Johnson, Unilever plc, Ultradent Products, Inc., 3M Company, Hain Celestial Group (Jason Natural Products, Inc.), Church & Dwight Co., Supersmile, and CloSYS among others.
US In Vitro Fertilization (IVF) Service Market Analysis
The US In Vitro Fertilization (IVF) Service Market was valued at $9429 Mn in 2023 and is predicted to grow at a CAGR of 5.42% from 2023 to 2030, to $13643.53 Mn by 2030. The key drivers of this industry include rising infertility rates, increasing disposable income, and technological advancements. The industry is primarily dominated by players such as CCRM Fertility, IVIRMA, ELITE IVF, and Boston IVF among others
US Bio-implant Market Analysis
The US Bio-implant Market was valued at $27300 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $35683.8 Mn by 2030. The US Bio-implant Market is growing due to Aging population, Rising prevalence of chronic diseases, Technological advancements. The market is primarily dominated by players such as Boston Scientific Corporation, Johnson & Johnson Services, Inc., Zimmer Biomet Holdings Inc, LifeNet Health, Smith & Nephew, Arthrex, Inc.
US Hemodialysis Equipment Market Analysis
The US Hemodialysis Equipment Market was valued at $5930.4 Mn in 2023 and is projected to grow at a CAGR of 5.6% from 2023 to 2023, to $8684.2 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Stryker, GE HealthCare, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.
US Dental Consumables Market Analysis
The US Dental Consumables Market was valued at $14196 Mn in 2023 and is projected to grow at a CAGR of 6.0% from 2023 to 2023, to $21345.5 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Anson Dental Supply, Align Technology, Zimmer Biomet, 3M, Carestream Dental among others.
US Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The US Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 2.8% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is effective treatment, increasing prevalence. The market is segmented By diagnostic method, by treatment, by type. Some key players in this market are Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera AB, Allena Pharmaceuticals, DOR BioPharma, Ardelyx, Emalex Bioscience, Mission Therapeutics, and BridgeBio Pharma, among others.
US Primary Hyperoxaluria (PH) Therapeutics Market Analysis
US Primary Hyperoxaluria (PH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. One of the key factors propelling the growth of the hyperoxaluria drug market is the rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Therapeutics Market are Allena Pharmaceuticals, Inc., Intellia Therapeutics, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
US Myelodysplastic Syndrome (MDS) Therapeutics Market Analysis
The US Myelodysplastic Syndrome (MDS) therapeutics market is projected to grow from $1.9 Bn in 2022 to $3.9 Bn by 2030, registering a CAGR of 9.3% during the forecast period of 2022-30. The market for pharmaceuticals for myelodysplastic syndrome (MDS) is growing as a result of a number of factors, including a rise in pediatric population, improved awareness, the launch of novel drugs, government initiatives to provide target-specific therapy, and favorable reimbursement policies. Major global players in this market are Abbott, Boehringer Ingelheim International GmbH, Johnson & Johnson Private Limited, MEI Pharma Inc., MTW Endoskopie Manufaktur, Aprea Therapeutics, Dr. Reddy's Laboratories Ltd, AbbVie Inc., Acceleron Pharma, Inc., Mylan N.V., Bristol-Myers Squibb Company, Eisai Co., Ltd., and LGM Pharma.
US Dental Caries Detectors Market Analysis
The US Dental Caries Detectors Market was valued at $95.8 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $152.9 Mn by 2030. US Dental Caries Detectors Market is growing due to the Prevalence of dental caries, Rising awareness, and Technological advancements. The industry is primarily dominated by players such as Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Planmeca Oy, Adec Technologies, 3M ESPE, Morita Corporation, Woodpecker Medical Instruments Co., Softdent.
US Clinical Nutrition for Diabetes Care Market Analysis
The US Clinical Nutrition for Diabetes Care Market was valued at $903 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $1094.08 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Perrigo Company PLC, Eli Lilly, and Baxter International Inc. among others.
US Pharmacy Automation Device Market Analysis
The US Pharmacy Automation Device Market was valued at $2310 Mn in 2023 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $3933.3 Mn by 2030. US Pharmacy Automation Device Market is growing due to Growing need to minimize medication errors, Rising Demand for Pharmaceuticals, and Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC, Becton Dickinson and Company, Fulcrum Pharmacy Management, Inc.
US Clinical Nutrition Market Analysis
The US Clinical Nutrition Market was valued at $12,881.4 Mn in 2023 and is projected to grow at a CAGR of 3.34% from 2023 to 2023, to $16,212.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd, Mead Johnson & Company, LLC among others.
US Mental Health Apps Market Analysis
The US Mental Health Apps Market was valued at $2604 Mn in 2023 and is predicted to grow at a CAGR of 13.2% from 2023 to 2030, to $6202.49 Mn by 2030. The key drivers of this industry include rising mental illness, reduced stigma, and increasing smartphone penetration. The industry is primarily dominated by players such as HeadSpace, Calm, Happify, and Ksana Health among others.
US Cardiac Pacemakers Market Analysis
The US Cardiac Pacemakers Market was valued at $1699.7 Mn in 2023 and is predicted to grow at a CAGR of 1.20% from 2023 to 2030, to $1847.72 Mn by 2030. The key drivers of this industry include the increasing aging population, the rising incidence of chronic disease, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
US Clinical Nutrition for Cancer Care Market Analysis
The US Clinical Nutrition for Cancer Care Market was valued at $2,364.6 Mn in 2023 and is predicted to grow at a CAGR of 3.04 % from 2023 to 2030, to $2,916.07 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, increased awareness and education, and increasing healthcare expenditure. The prominent players of the US Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, Pfizer, and Fresenius Kabi, among others.
US Gram-Negative Infection Therapeutics Market Analysis
The US Gram-Negative Infection Therapeutics Market was valued at $6247.5 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030 to $8166.1 Mn by 2030. A key factor driving this market growth is decreasing antibiotic resistance trends in gram-negative bacteria, increasing prevalence, and innovative therapeutics. Leading companies in this market include Pfizer Inc. and AbbVie Inc. (Allergan Pharmaceuticals Private Limited), among others.
US Home Infusion Therapy Market
The US Home Infusion Therapy Market was valued at $15103.2 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $22860 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the US Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
US Hepatitis A Therapeutics Market Analysis
The US Hepatitis A Therapeutics Market was valued at $309.62 Mn in 2023 and is predicted to grow at a CAGR of 0.2% from 2023 to 2030 to $313.98 Mn by 2030. One of the key drivers of this industry includes disease prevalence and therapeutic demand, as evidenced by a 270% increase in reported cases to 12,474 in 2018, followed by a continued rise to 18,846 cases and above. The top players are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., etc.
US Frontotemporal Disorders Therapeutics Market Analysis
US Glioblastoma Multiforme Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Neurons in the frontal and temporal lobes of the brain are damaged in frontotemporal diseases (FTD), also known as frontotemporal dementia. As the patient population for FTD is growing, non-profit organisations, illness advocacy groups, and private organisations are currently concentrating on supporting treatment research. A major driver of the frontotemporal disorders treatment market growth is predicted to be the rising life expectancy rate, which is also expected to contribute to the increasing prevalence of neurological diseases among the older population. Apotex Inc., AstraZeneca plc., Auro Pharma, Johnson & Johnson, Mylan N.V., Pfizer Inc., Sanofi S.A., and Teva Pharmaceuticals USA, Inc. are just a few of the well-known worldwide and local businesses that are examined in the competitive landscape.
US Sanfilippo Syndrome (MPS-III) Therapeutics Market Analysis
US Sanfilippo Syndrome (MPS-III) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sanfilippo Syndrome (MPS-III) Therapeutics is growing rapidly as a result of increase in research and development activities, patient support and advocacy programmes, launch of new emerging therapies, increase in healthcare spending globally. Phoenix Nest Inc, Allievex Corp, Amicus Therapeutics Inc, ArmaGen Inc, Esteve Pharmaceuticals SA, JCR Pharmaceuticals Co Ltd, M6P Therapeutics, Orchard Therapeutics Plc, Seelos Therapeutics, Inc., and BioStrategies LC are top key players operating in global Sanfilippo Syndrome (MPS-III) Therapeutics market.
US Pseudomonas Aeruginosa Infection Therapeutics Market Analysis
US Pseudomonas Aeruginosa Infection Therapeutics Market is projected to grow from $0.55 Bn in 2022 to $0.74 Bn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-2030. Industry income is expected to increase as a result of increased pseudomonas aeruginosa infections, an ageing population, future innovative antibiotic formulations, an increase in patients, and greater public awareness of the infection. Major global players in Pseudomonas Aeruginosa Infection Therapeutics Market are Allergan, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Lupin Pharmaceuticals, Inc., AstraZeneca, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc, Merck & Co.
US Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics Market Analysis
US Fibrodysplasia Ossificans Progressiva Therapeutics Market is projected to grow from $0.21 Bn in 2022 to $0.25 Bn by 2030, registering a CAGR of 2.0% during the forecast period of 2023 ? 2030. An estimated 1.36 per Mn persons are believed to have the ultra-rare condition fibrodysplasia osseous progressiva, which affects about 900 people worldwide. The market for Fibrodysplasia Ossificans Progressiva Drugs is expanding as a result of growing incidence and prevalence of fibrodysplasia ossificans progressiva, increase in the number of R&D activities, increase in Partnerships and Collaborations between market players. Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, Novartis are the top key market players operating in the global Fibrodysplasia Ossificans Progressiva Therapeutics Market.
US Lymphoma Therapeutics Market Analysis
US Lymphoma Therapeutics Market was valued at $2,914.80 Mn in 2023 and is predicted to grow at a CAGR of 6.30%from 2023 to 2030, to $4,470.35 Mn by 2030. The key drivers of this industry include the rising prevalence of lymphoma, growing label extension, strong product pipeline, and rising geriatric population. The industry is primarily dominated by Bristol-Myers Squibb Company, Celgene Corporation, Merck & Co., Inc., and F. Hoffmann-La Roche Ltd, among others.
US Head and Neck Cancer Therapeutics Market Analysis
The US Head and Neck Cancer Therapeutics Market was valued at $512.40 Mn in 2023 and is predicted to grow at a CAGR of 10.50% from 2023 to 2030, to $1030.73 Mn by 2030. The key drivers of this industry include the rising prevalence of Head and Neck cancer, improvement in diagnostic techniques, and growing awareness. The industry is primarily dominated by players such as Eli Lilly and Company, Merck, Bristol Myers Squibb, and AstraZeneca among others.
US Virtual Clinical Trials Market Analysis
This report presents a strategic analysis of the US Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Virtual Clinical Trials Market, offering unmatched value, accuracy and expert insights.